Company Performance: The profitability, revenue growth, and overall financial health of Jiangsu Hengrui Medicine Co., Ltd. (600399.SHG) directly impact its stock price.

Industry Trends: Developments in the pharmaceutical industry, including new drug approvals, regulatory changes, and competitive landscape shifts influence investor sentiment and the stock's valuation.

Market Sentiment: Broad market conditions, such as overall investor confidence, economic outlook, and global events, can affect the demand for 600399.SHG shares.

Regulatory Environment: Government regulations related to drug pricing, healthcare policies, and intellectual property rights significantly impact the profitability and growth prospects of the company.

Research and Development: Successful development and commercialization of new drugs are crucial for Hengrui Medicine's future growth, positively affecting the stock price.

Competition: The presence and performance of competitor companies in the pharmaceutical industry can influence investor perceptions of Hengrui Medicine's market share and future prospects.

Economic Factors: Macroeconomic conditions, including interest rates, inflation, and GDP growth, can impact the overall stock market and influence investor behavior towards 600399.SHG.

Global Events: International events, such as trade wars, geopolitical tensions, and global health crises, can create uncertainty and volatility in the stock market, affecting the stock price.

Investor Sentiment: Investor beliefs, expectations, and trading behavior can impact the demand for and supply of 600399.SHG shares, thus affecting its price.

Financial Reports: Quarterly and annual earnings reports, along with management guidance, provide insights into the company's financial performance and influence investor expectations.